Edition:
United States

Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

3.47GBp
2 Dec 2016
Change (% chg)

0.00p (+0.00%)
Prev Close
3.50p
Open
3.50p
Day's High
3.50p
Day's Low
3.40p
Volume
7,212,129
Avg. Vol
3,791,731
52-wk High
8.45p
52-wk Low
2.98p

OXB.L

Chart for OXB.L

About

Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company's segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners. The R&D... (more)

Overall

Beta: 0.35
Market Cap(Mil.): £104.22
Shares Outstanding(Mil.): 3,087.95
Dividend: --
Yield (%): --

Financials

  OXB.L Industry Sector
P/E (TTM): -- 42.21 29.87
EPS (TTM): -0.01 -- --
ROI: -43.95 -1.09 14.95
ROE: -122.72 -2.39 16.29

BRIEF-Oxford Biomedica inks strategic alliance with Orchard Therapeutics

* Oxford Biomedica announces a strategic alliance with Orchard Therapeutics

Nov 29 2016

BRIEF-Oxford BioMedica grants to MolMed non-exclusive licence under its LentiVector platform technology

* Signs with Oxford BioMedica new non-exclusive licence agreement concerning lentiviral vector technology

Jun 07 2016

Earnings vs. Estimates